Private company

Athira Pharma

Logo: Athira Pharma, Public domain, via Wikimedia Commons⁴

Athira Pharma is a late clinical stage American biopharmaceutical company developing small-molecule therapeutics targeting neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021.² It was founded in 2011.¹ It is headquartered in Seattle.¹ Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

2011Founded¹

HeadquartersSeattle¹
Websitewww.athira.com
Legal formCorporation³
LEI529900CSS4S4X8VY5C81³
StatusActive³
LEI statusLapsed (not renewed)³
Registered addressc/o Corporation Service Company, 251 Little Falls Drive, 19808 Wilmington, United States³
Registered withDivision of Corporations, Department of State, 5861845³

See how the biggest companies compare on our leaderboards

Timeline

2011Founded Founded¹

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$215.0K 2020–2020

PPP loans $215.0K

Figures by year

Year	PPP loans	Total
2020	$215.0K	$215.0K

PPP loans

Paycheck Protection Program loans of $150,000 and up, approved April 2020 to July 2021, from the SBA⁵. Matched to this company by name and state.

Apr 10, 2020$215.0K PPP loan (first draw) from JPMorgan Chase Bank, National Association⁵To ATHIRA PHARMA, INC., Seattle WA; no forgiveness recorded

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataAthira Pharma on Wikidata
2
WikipediaAthira Pharma on Wikipedia
3
GLEIFAthira Pharma LEI record (529900CSS4S4X8VY5C81)
4
Wikimedia CommonsAthira Pharma logo by Athira Pharma, Public domain
5
SBASBA Paycheck Protection Program loan data (FOIA), loans of $150,000 and up

Overview

Timeline

Funding

PPP loans

Links

Sources